Enhanced S100 calcium-binding protein P expression sensitizes human bladder cancer cells to cisplatin

Masaki Shiota, Toshiyuki Tsunoda, Yoohyun Song, Akira Yokomizo, Yasuhiro Tada, Yoshinao Oda, Seiji Naito

Research output: Contribution to journalArticle

13 Citations (Scopus)

Abstract

OBJECTIVE: To investigate the role of S100 calcium-binding protein P (S100P) in the gain of cis-diamminedichloroplatinum (II) (cisplatin) resistance in bladder cancer, having previously found, with cDNA microarrays using two pairs of parental (T24, KK47) and their cisplatin-resistant bladder cancer cell lines (T24/DDP10, KK47/DDP20), that S100P mRNA expression was significantly reduced in cisplatin-resistant cells. MATERIALS AND METHODS S100P mRNA and protein expression levels were investigated by northern and western blot analyses, respectively. Intracellular S100P localization was examined by immunocytochemistry and immunohistochemistry. S100P over-expression, obtained by transfection with S100P expression plasmid, was used to investigate whether or not S100P affected cellular resistance to cisplatin. RESULTS S100P mRNA showed increased expression by cisplatin stimulation in parental cell lines. On the other hand, S100P mRNA and protein expression levels were markedly reduced in cisplatin-resistant cells. The over-expression of S100P in resistant cells resulted in an increased sensitivity to cisplatin. CONCLUSIONS In bladder cancer cells, S100P was expressed and localized mainly in the nucleus. S100P expression was also involved in cisplatin sensitivity. S100P might thus represent a molecular marker predicting cisplatin sensitivity and a molecular therapeutic target for cisplatin-based chemotherapy.

Original languageEnglish
Pages (from-to)1148-1153
Number of pages6
JournalBJU international
Volume107
Issue number7
DOIs
Publication statusPublished - Apr 1 2011

Fingerprint

Calcium-Binding Proteins
Urinary Bladder Neoplasms
Cisplatin
Messenger RNA
Immunohistochemistry
Cell Line
Oligonucleotide Array Sequence Analysis
Northern Blotting
Transfection
Proteins
Plasmids
Western Blotting

All Science Journal Classification (ASJC) codes

  • Urology

Cite this

Enhanced S100 calcium-binding protein P expression sensitizes human bladder cancer cells to cisplatin. / Shiota, Masaki; Tsunoda, Toshiyuki; Song, Yoohyun; Yokomizo, Akira; Tada, Yasuhiro; Oda, Yoshinao; Naito, Seiji.

In: BJU international, Vol. 107, No. 7, 01.04.2011, p. 1148-1153.

Research output: Contribution to journalArticle

Shiota, Masaki ; Tsunoda, Toshiyuki ; Song, Yoohyun ; Yokomizo, Akira ; Tada, Yasuhiro ; Oda, Yoshinao ; Naito, Seiji. / Enhanced S100 calcium-binding protein P expression sensitizes human bladder cancer cells to cisplatin. In: BJU international. 2011 ; Vol. 107, No. 7. pp. 1148-1153.
@article{1c75222b2f6a44eca8fc9082bdb04ee2,
title = "Enhanced S100 calcium-binding protein P expression sensitizes human bladder cancer cells to cisplatin",
abstract = "OBJECTIVE: To investigate the role of S100 calcium-binding protein P (S100P) in the gain of cis-diamminedichloroplatinum (II) (cisplatin) resistance in bladder cancer, having previously found, with cDNA microarrays using two pairs of parental (T24, KK47) and their cisplatin-resistant bladder cancer cell lines (T24/DDP10, KK47/DDP20), that S100P mRNA expression was significantly reduced in cisplatin-resistant cells. MATERIALS AND METHODS S100P mRNA and protein expression levels were investigated by northern and western blot analyses, respectively. Intracellular S100P localization was examined by immunocytochemistry and immunohistochemistry. S100P over-expression, obtained by transfection with S100P expression plasmid, was used to investigate whether or not S100P affected cellular resistance to cisplatin. RESULTS S100P mRNA showed increased expression by cisplatin stimulation in parental cell lines. On the other hand, S100P mRNA and protein expression levels were markedly reduced in cisplatin-resistant cells. The over-expression of S100P in resistant cells resulted in an increased sensitivity to cisplatin. CONCLUSIONS In bladder cancer cells, S100P was expressed and localized mainly in the nucleus. S100P expression was also involved in cisplatin sensitivity. S100P might thus represent a molecular marker predicting cisplatin sensitivity and a molecular therapeutic target for cisplatin-based chemotherapy.",
author = "Masaki Shiota and Toshiyuki Tsunoda and Yoohyun Song and Akira Yokomizo and Yasuhiro Tada and Yoshinao Oda and Seiji Naito",
year = "2011",
month = "4",
day = "1",
doi = "10.1111/j.1464-410X.2010.09535.x",
language = "English",
volume = "107",
pages = "1148--1153",
journal = "BJU International",
issn = "1464-4096",
publisher = "Wiley-Blackwell",
number = "7",

}

TY - JOUR

T1 - Enhanced S100 calcium-binding protein P expression sensitizes human bladder cancer cells to cisplatin

AU - Shiota, Masaki

AU - Tsunoda, Toshiyuki

AU - Song, Yoohyun

AU - Yokomizo, Akira

AU - Tada, Yasuhiro

AU - Oda, Yoshinao

AU - Naito, Seiji

PY - 2011/4/1

Y1 - 2011/4/1

N2 - OBJECTIVE: To investigate the role of S100 calcium-binding protein P (S100P) in the gain of cis-diamminedichloroplatinum (II) (cisplatin) resistance in bladder cancer, having previously found, with cDNA microarrays using two pairs of parental (T24, KK47) and their cisplatin-resistant bladder cancer cell lines (T24/DDP10, KK47/DDP20), that S100P mRNA expression was significantly reduced in cisplatin-resistant cells. MATERIALS AND METHODS S100P mRNA and protein expression levels were investigated by northern and western blot analyses, respectively. Intracellular S100P localization was examined by immunocytochemistry and immunohistochemistry. S100P over-expression, obtained by transfection with S100P expression plasmid, was used to investigate whether or not S100P affected cellular resistance to cisplatin. RESULTS S100P mRNA showed increased expression by cisplatin stimulation in parental cell lines. On the other hand, S100P mRNA and protein expression levels were markedly reduced in cisplatin-resistant cells. The over-expression of S100P in resistant cells resulted in an increased sensitivity to cisplatin. CONCLUSIONS In bladder cancer cells, S100P was expressed and localized mainly in the nucleus. S100P expression was also involved in cisplatin sensitivity. S100P might thus represent a molecular marker predicting cisplatin sensitivity and a molecular therapeutic target for cisplatin-based chemotherapy.

AB - OBJECTIVE: To investigate the role of S100 calcium-binding protein P (S100P) in the gain of cis-diamminedichloroplatinum (II) (cisplatin) resistance in bladder cancer, having previously found, with cDNA microarrays using two pairs of parental (T24, KK47) and their cisplatin-resistant bladder cancer cell lines (T24/DDP10, KK47/DDP20), that S100P mRNA expression was significantly reduced in cisplatin-resistant cells. MATERIALS AND METHODS S100P mRNA and protein expression levels were investigated by northern and western blot analyses, respectively. Intracellular S100P localization was examined by immunocytochemistry and immunohistochemistry. S100P over-expression, obtained by transfection with S100P expression plasmid, was used to investigate whether or not S100P affected cellular resistance to cisplatin. RESULTS S100P mRNA showed increased expression by cisplatin stimulation in parental cell lines. On the other hand, S100P mRNA and protein expression levels were markedly reduced in cisplatin-resistant cells. The over-expression of S100P in resistant cells resulted in an increased sensitivity to cisplatin. CONCLUSIONS In bladder cancer cells, S100P was expressed and localized mainly in the nucleus. S100P expression was also involved in cisplatin sensitivity. S100P might thus represent a molecular marker predicting cisplatin sensitivity and a molecular therapeutic target for cisplatin-based chemotherapy.

UR - http://www.scopus.com/inward/record.url?scp=79953208052&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79953208052&partnerID=8YFLogxK

U2 - 10.1111/j.1464-410X.2010.09535.x

DO - 10.1111/j.1464-410X.2010.09535.x

M3 - Article

C2 - 20726978

AN - SCOPUS:79953208052

VL - 107

SP - 1148

EP - 1153

JO - BJU International

JF - BJU International

SN - 1464-4096

IS - 7

ER -